Evidence map›Paper›PMID 36096333›Full record

Trial reportJournal of virological methods2022

Effect of the environment on home-based self-sampling kits for anal cancer screening.

Jenna Nitkowski, Anna Giuliano, Tim Ridolfi, Elizabeth Chiao, Maria E Fernandez, Vanessa Schick, Michael D Swartz, Jennifer S Smith, Ellen A Schneider, Bridgett Brzezinski and 1 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of virological methods, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Jenna NitkowskiCenter for AIDS Intervention Research, Medical College of Wisconsin, Milwaukee, WI, USA. Electronic address: jnitkowski@mcw.edu.
Anna GiulianoCenter for Immunization and Infection Research in Cancer, Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Tim RidolfiClinical Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA.
Elizabeth ChiaoMD Anderson Cancer Center, The University of Texas, Houston, TX, USA.
Maria E FernandezDepartment of Health Promotion and Behavioral Sciences, The University of Texas Health Science Center at Houston School of Public Health, Houston, TX, USA.
Vanessa SchickDepartment of Management, Policy and Community Health, The University of Texas Health Science Center at Houston School of Public Health, Houston, TX, USA.
Michael D SwartzDepartment of Biostatistics and Data Science, The University of Texas Health Science Center at Houston School of Public Health, Houston, TX, USA.
Jennifer S SmithGillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Ellen A SchneiderDepartment of Pathology, MCW Tissue Bank, Medical College of Wisconsin, Milwaukee, WI, USA.
Bridgett BrzezinskiCenter for AIDS Intervention Research, Medical College of Wisconsin, Milwaukee, WI, USA.
Alan G NyitrayCenter for AIDS Intervention Research, Medical College of Wisconsin, Milwaukee, WI, USA; Clinical Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA.
Medical College of Wisconsin · USThe University of Texas Health Science Center at Houston · USMoffitt Cancer Center · USThe University of Texas MD Anderson Cancer Center · USUniversity of North Carolina at Chapel Hill · US

Funding

Clinical and Translational Science AwardUL1TR001436 · NCATS · MEDICAL COLLEGE OF WISCONSIN · PI FREED, JULIE K · 2015 to 2025
$47.5M
Annual anal sampling using DNA screening to identify men who have sex with men at increased risk for anal cancerR01CA215403 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI NYITRAY, ALAN GASPAR · 2017 to 2021
$2.8M
NCATS NIH HHS UL1 TR001436NCI NIH HHS R01 CA215403
6 · The paper itself

Abstract

backgroundAnal cancer incidence has increased in Western countries in recent decades and currently there are no consensus screening guidelines. Home-based self-sampling kits might facilitate screening for anal precancer/cancer but could require travel through postal mail where they may experience extreme temperatures or long transport times.

objectiveTo determine the effect of the environment on specimen adequacy for HPV genotyping of a mailed home-based self-sampling anal cancer screening kit. STUDY

designThe Prevent Anal Cancer (PAC) Study in Milwaukee, Wisconsin recruited men who have sex with men (MSM) and transgender persons 25 years of age and older. Participants were randomized to receive a mailed self-sampling kit or attend a clinic for screening. Kits were insulated with foam and included a device to record temperature every twenty minutes. Samples were returned via mail and underwent HPV genotyping using the SPF

resultsMost specimens (92.5%) were adequate for HPV genotyping. Specimen inadequacy was not associated with temperature, freeze-thaw cycle, or transit time. Fecal matter was present more often in inadequate (71.4%) compared to adequate specimens (16.3%) (p = .004).

conclusionsThese real-world data from mailed home-based anal self-sampling kits found that environmental conditions did not affect specimen adequacy. While over 90% of specimens were adequate, presence of fecal matter predicted specimen inadequacy.

Indexed as

Anus NeoplasmsPapillomavirus InfectionsSexual and Gender MinoritiesEarly Detection of CancerHomosexuality, MaleHumansMalePapillomaviridaeRibonuclease PRibonuclease PAnal cancerHuman papillomavirus (HPV)MSMSelf-samplingSpecimen adequacyTemperature

Identifiers

PMID36096333
PMCPMC9645463
OpenAlexW4295519758

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.